Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Tsuji

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Pharmacotherapy|January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale usePhillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotypeJustin R Lenhard, Christof von Eiff, Irene S Hong, et al.
International Journal of Antimicrobial Agents|June 30, 2024
PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguiseNicholas M Smith, Katie Rose Boissonneault, Patricia N Holden, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Scientific Reports|May 20, 2016
Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage RegimensSoon-Ee Cheah, Matthew D Johnson, Yan Zhu, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faeciumGeorge Sakoulas, Arnold S Bayer, Joseph Pogliano, et al.
International Journal of Antimicrobial Agents|February 28, 2018
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection modelZackery P Bulman, Miao Zhao, Michael J Satlin, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2024
Maximally precise combinations to overcome metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>Jan Naseer Kaur, Jack F Klem, Yang Liu, et al.
International Journal of Antimicrobial Agents|October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumanniiJustin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic modelPhillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Pharmacotherapy|January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale usePhillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotypeJustin R Lenhard, Christof von Eiff, Irene S Hong, et al.
International Journal of Antimicrobial Agents|June 30, 2024
PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguiseNicholas M Smith, Katie Rose Boissonneault, Patricia N Holden, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Scientific Reports|May 20, 2016
Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage RegimensSoon-Ee Cheah, Matthew D Johnson, Yan Zhu, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faeciumGeorge Sakoulas, Arnold S Bayer, Joseph Pogliano, et al.
International Journal of Antimicrobial Agents|February 28, 2018
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection modelZackery P Bulman, Miao Zhao, Michael J Satlin, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2024
Maximally precise combinations to overcome metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>Jan Naseer Kaur, Jack F Klem, Yang Liu, et al.
International Journal of Antimicrobial Agents|October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumanniiJustin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic modelPhillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Pageof 11